BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang SM, Han C, Lee SJ, Jun TY, Patkar AA, Masand PS, Pae CU. Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update. Chonnam Med J 2016;52:159-72. [PMID: 27689026 DOI: 10.4068/cmj.2016.52.3.159] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Fornaro M, Fusco A, Anastasia A, Cattaneo CI, De Berardis D. Brexpiprazole for treatment-resistant major depressive disorder. Expert Opinion on Pharmacotherapy 2019;20:1925-33. [DOI: 10.1080/14656566.2019.1654457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
2 Seetasith A, Greene M, Hartry A, Burudpakdee C. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder. Journal of Medical Economics 2018;21:888-901. [DOI: 10.1080/13696998.2018.1484373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
3 Behrman S, Burgess J, Topiwala A. Prescribing antipsychotics in older people: A mini-review. Maturitas 2018;116:8-10. [DOI: 10.1016/j.maturitas.2018.06.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Juza R, Stefkova K, Dehaen W, Randakova A, Petrasek T, Vojtechova I, Kobrlova T, Pulkrabkova L, Muckova L, Mecava M, Prchal L, Mezeiova E, Musilek K, Soukup O, Korabecny J. Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D2 3,4-dihydroquinolin-2(1H)-one Derivatives Related to Aripiprazole. Biomolecules 2021;11:1262. [PMID: 34572475 DOI: 10.3390/biom11091262] [Reference Citation Analysis]
5 Fugger G, Bartova L, Dold M, Fabbri C, Fanelli G, Zanardi R, Kautzky A, Zohar J, Souery D, Mendlewicz J, Montgomery S, Rujescu D, Serretti A, Kasper S. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2022;114:110480. [PMID: 34826558 DOI: 10.1016/j.pnpbp.2021.110480] [Reference Citation Analysis]
6 Kern DM, Cepeda MS, Defalco F, Etropolski M. Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019. BMC Psychiatry 2020;20:4. [PMID: 31900133 DOI: 10.1186/s12888-019-2418-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
7 Chen P. Optimized Treatment Strategy for Depressive Disorder. In: Fang Y, editor. Depressive Disorders: Mechanisms, Measurement and Management. Singapore: Springer; 2019. pp. 201-17. [DOI: 10.1007/978-981-32-9271-0_11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Kutzer T, Dick M, Scudamore T, Wiener M, Schwartz T. Antidepressant efficacy and side effect burden: an updated guide for clinicians. Drugs Context 2020;9:2020-2-2. [PMID: 32523610 DOI: 10.7573/dic.2020-2-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Endomba FT, Tankeu AT, Nkeck JR, Tochie JN. Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain? Lipids Health Dis 2020;19:22. [PMID: 32033608 DOI: 10.1186/s12944-020-01203-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
10 Włodarczyk A, Cubała WJ, Stawicki M. Ketogenic diet for depression: A potential dietary regimen to maintain euthymia? Prog Neuropsychopharmacol Biol Psychiatry 2021;109:110257. [PMID: 33497756 DOI: 10.1016/j.pnpbp.2021.110257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Bartova L, Fugger G, Dold M, Kautzky A, Swoboda MMM, Rujescu D, Zohar J, Souery D, Mendlewicz J, Montgomery S, Fabbri C, Serretti A, Kasper S. The Choice of either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients with Major Depressive Disorder. Int J Neuropsychopharmacol 2021:pyab066. [PMID: 34637516 DOI: 10.1093/ijnp/pyab066] [Reference Citation Analysis]
12 Cheng Q, Huang J, Xu L, Li Y, Li H, Shen Y, Zheng Q, Li L. Analysis of Time-Course, Dose-Effect, and Influencing Factors of Antidepressants in the Treatment of Acute Adult Patients With Major Depression. Int J Neuropsychopharmacol 2020;23:76-87. [PMID: 31774497 DOI: 10.1093/ijnp/pyz062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Han C, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Pae CU. The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study. Clin Psychopharmacol Neurosci 2019;17:495-502. [PMID: 31671486 DOI: 10.9758/cpn.2019.17.4.495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Tanana L, Latif A, Nishtala PS, Taylor D, Chen TF. An International Comparison of the Information in the Regulatory-Approved Drug Labeling and Prescribing Guidelines for Pediatric Depression. J Child Adolesc Psychopharmacol 2021;31:294-309. [PMID: 33601936 DOI: 10.1089/cap.2020.0154] [Reference Citation Analysis]
15 Catalano G, Robeel RA, Cheney GA, Spurling BC, Catalano MC, Schultz SK, Sanchez DL. Antidepressant Augmentation: A Review of the Literature and a Review of the Pharmacoeconomic Considerations. J Clin Psychopharmacol 2020;40:396-400. [PMID: 32639292 DOI: 10.1097/JCP.0000000000001236] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Domingues M, Casaril AM, Birmann PT, Lourenço DA, Vieira B, Begnini K, Lenardão EJ, Collares T, Seixas FK, Savegnago L. Selanylimidazopyridine Prevents Lipopolysaccharide-Induced Depressive-Like Behavior in Mice by Targeting Neurotrophins and Inflammatory/Oxidative Mediators. Front Neurosci 2018;12:486. [PMID: 30072867 DOI: 10.3389/fnins.2018.00486] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
17 Zheng M, Zhang C, Wang L, Wang K, Kang W, Lian K, Li H. Determination of nine mental drugs in human plasma using solid-phase supported liquid-liquid extraction and HPLC-MS/MS. Microchemical Journal 2021;160:105647. [DOI: 10.1016/j.microc.2020.105647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Sakurai H, Yasui-Furukori N, Suzuki T, Uchida H, Baba H, Watanabe K, Inada K, Kikuchi YS, Kikuchi T, Katsuki A, Kishida I, Kato M. Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus. Pharmacopsychiatry 2021;54:60-7. [PMID: 33434943 DOI: 10.1055/a-1324-3517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Dome P, Tombor L, Lazary J, Gonda X, Rihmer Z. Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review. Brain Research Bulletin 2019;146:51-78. [DOI: 10.1016/j.brainresbull.2018.12.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
20 Rege S, Sura S, Aparasu RR. Atypical antipsychotic prescribing in elderly patients with depression. Research in Social and Administrative Pharmacy 2018;14:645-52. [DOI: 10.1016/j.sapharm.2017.07.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Bauer M, Severus E, Möller H, Young AH; WFSBP Task Force on Unipolar Depressive Disorders. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines. International Journal of Psychiatry in Clinical Practice 2017;21:166-76. [DOI: 10.1080/13651501.2017.1306082] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
22 Chen X, Liang C, Cui L, Le J, Qian Z, Zhang R, Hong Z, Chai Y. A rapid LC-MS/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study. J Food Drug Anal 2019;27:323-31. [PMID: 30648587 DOI: 10.1016/j.jfda.2018.07.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
23 Wang MT, Lin CW, Tsai CL, Wang YH, Lai JH, Yeh CB, Huang YL, Hsu YJ. Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score-matched nested case-control study. Br J Clin Pharmacol 2020;86:2204-16. [PMID: 32337738 DOI: 10.1111/bcp.14321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Cheng T. Late-Life Depression. In: Hategan A, Bourgeois JA, Hirsch CH, Giroux C, editors. Geriatric Psychiatry. Cham: Springer International Publishing; 2018. pp. 219-35. [DOI: 10.1007/978-3-319-67555-8_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Kasper S, Cubała WJ, Fagiolini A, Ramos-Quiroga JA, Souery D, Young AH. Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance. World J Biol Psychiatry 2021;22:468-82. [PMID: 33138665 DOI: 10.1080/15622975.2020.1836399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Cummings JL, Tong G, Ballard C. Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options. J Alzheimers Dis 2019;67:779-94. [PMID: 30689575 DOI: 10.3233/JAD-180766] [Cited by in Crossref: 90] [Cited by in F6Publishing: 38] [Article Influence: 45.0] [Reference Citation Analysis]
27 Kim Y, Wang SM, Kwak KP, Yoon HK, Pae CU, Kim JJ, Bahk WM. Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study. Clin Psychopharmacol Neurosci 2016;14:371-7. [PMID: 27776390 DOI: 10.9758/cpn.2016.14.4.371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
28 Chen X, Zheng S, Le J, Qian Z, Zhang R, Hong Z, Chai Y. Ultrasound-assisted low-density solvent dispersive liquid–liquid microextraction for the simultaneous determination of 12 new antidepressants and 2 antipsychotics in whole blood by gas chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2017;142:19-27. [DOI: 10.1016/j.jpba.2017.04.032] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
29 Broder MS, Greene M, Yan T, Chang E, Hartry A, Yermilov I. Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment. Clin Ther 2019;41:221-32. [PMID: 30616973 DOI: 10.1016/j.clinthera.2018.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
30 Keenan R, Chepulis L, Ly J, Carter S, Lao C, Asim M, Bhat A, Deo S, Lim KP, Mohammed R, Scarlet S, Lawrenson R. Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication. J Prim Health Care 2020;12:29-34. [PMID: 32223847 DOI: 10.1071/HC19023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
31 Kern DM, Cepeda MS, Castilla-Puentes RC, Savitz A, Etropolski M. Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting. Curr Med Res Opin 2021;37:1377-84. [PMID: 33818238 DOI: 10.1080/03007995.2021.1911975] [Reference Citation Analysis]